Status:
RECRUITING
Culturally Tailored Diabetes Education on Self-Management of Adult Hispanic Males With Type 2 Diabetes Mellitus
Lead Sponsor:
Hackensack Meridian Health
Conditions:
Diabetes Mellitus
Diabete Type 2
Eligibility:
MALE
18-64 years
Phase:
NA
Brief Summary
Diabetes mellitus (DM) is a global public health concern. In the United States, adult Hispanic males are particularly vulnerable to type 2 diabetes mellitus and are more likely to develop complication...
Eligibility Criteria
Inclusion
- Age: Adult Hispanic males 18-64 at time of study intervention.
- Diagnosis Codes: Patients with self-reported diagnosis of T2DM without complex, co-morbid conditions such as severe kidney disease and terminal illnesses such as cancer.
- English or Spanish speaking
Exclusion
- Outside the age range listed above
- Without a diagnosis of type 2 diabetes
Key Trial Info
Start Date :
September 12 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 11 2026
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT06897618
Start Date
September 12 2025
End Date
September 11 2026
Last Update
September 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hackensack Meridian Health, JFK University Medical
Plainfield, New Jersey, United States, 07060